Form 4: Zimmer Biomet Executive Sang Yi Reports Stock Transactions
SEC Form 4 Filing
Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reports the vesting and conversion of restricted stock units into common stock.
Summary
- On March 6, 2025, Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reported transactions involving Zimmer Biomet common stock.
- Specifically, 2,365 restricted stock units (RSUs) vested and were converted into 2,365 shares of common stock.
- Following the transaction, Yi directly owns 2,364 derivative securities and 21,424 shares of common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of transaction: vesting of restricted stock units and conversion to common stock |
| 03/06/2026 | Date of remaining RSUs vest |
| 03/07/2025 | Date of report filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.